Related Experiment Video
Updated: May 6, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Negative control of p53 by Sir2alpha promotes cell survival under stress
1Institute of Cancer Genetics and Department of Pathology, College of Physicians & Surgeons, Columbia University, 1150 St. Nicholas Avenue, New York, NY 10032, USA.
Abstract:
The NAD-dependent histone deacetylation of Sir2 connects cellular metabolism with gene silencing as well as aging in yeast. Here, we show that mammalian Sir2alpha physically interacts with p53 and attenuates p53-mediated functions. Nicotinamide (Vitamin B3) inhibits an NAD-dependent p53 deacetylation induced by Sir2alpha, and also enhances the p53 acetylation levels in vivo. Furthermore, Sir2alpha represses p53-dependent apoptosis in response to DNA damage and oxidative stress, whereas expression of a Sir2alpha point mutant increases the sensitivity of cells in the stress response. Thus, our findings implicate a p53 regulatory pathway mediated by mammalian Sir2alpha. These results have significant implications regarding an important role for Sir2alpha in modulating the sensitivity of cells in p53-dependent apoptotic response and the possible effect in cancer therapy.
Insights
Mammalian Sir2alpha interacts with p53, inhibiting its function and repressing apoptosis. Nicotinamide (Vitamin B3) blocks this deacetylation, impacting cellular stress response and cancer therapy.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Sir2 proteins are NAD-dependent deacetylases linking metabolism to gene silencing and aging.
- Mammalian Sir2 homologs, including Sir2alpha, are implicated in various cellular processes.
Purpose of the Study:
- To investigate the interaction between mammalian Sir2alpha and the tumor suppressor p53.
- To elucidate the role of Sir2alpha in regulating p53-mediated functions, including apoptosis and cellular stress responses.
Main Methods:
- Co-immunoprecipitation assays to demonstrate physical interaction between Sir2alpha and p53.
- In vivo and in vitro experiments to assess the effect of Sir2alpha on p53 acetylation and deacetylation.
- Cellular assays measuring apoptosis and stress response in the presence of Sir2alpha or its mutant.
Main Results:
- Mammalian Sir2alpha physically interacts with p53.
- Sir2alpha attenuates p53-mediated transcriptional activity and DNA binding.
- Nicotinamide (Vitamin B3) inhibits Sir2alpha-induced p53 deacetylation and enhances p53 acetylation in vivo.
- Sir2alpha represses p53-dependent apoptosis induced by DNA damage and oxidative stress.
- Expression of a Sir2alpha point mutant sensitizes cells to stress-induced apoptosis.
Conclusions:
- Mammalian Sir2alpha plays a critical role in a p53 regulatory pathway.
- Sir2alpha modulates cellular sensitivity to p53-dependent apoptosis.
- Targeting the Sir2alpha-p53 interaction may offer novel therapeutic strategies for cancer.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Regulation of the Unfolded Protein Response
DNA Damage Can Stall the Cell Cycle

